B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features (Q35193688)

7 August 2017

1 reference

title

B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features (English)

1 reference

B-cell chronic lymphocytic leukemia

7 August 2017

0 references

1 reference

1 reference

6

Hélène Merle-Béral

0 references

Ludovic Deriano

object named as

Ludovic Deriano

2

0 references

Laure Sabatier

object named as

Laure Sabatier

5

0 references

author name string

Olivier Guipaud

1

1 reference

7 August 2017

Hélène Salin

3

1 reference

7 August 2017

Laurent Vallat

4

1 reference

7 August 2017

Jozo Delic

7

1 reference

7 August 2017

publication date

1 August 2003

1 reference

Lancet Oncology Commission

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

505-514

1 reference

Chronic lymphocytic leukaemia: one disease or two?

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Morphological and immunophenotypic features of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

When and how to treat chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

A Multicentric Study of 41 Cases of B-Prolymphocytic Leukemia: Two Evolutive Forms: The Groupe Français d'Hématologie Cellulaire

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Genetic features of B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Emerging information on the use of rituximab in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Advances in classification and therapy of indolent B-cell malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Progress in CLL, chemotherapy, antibodies and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Lymphocide: cytokines and the control of lymphoid homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Clinical efficacy of irradiation in CLL patients: predictive value of in vitro radio-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Increased sensitivity of CLL-derived lymphocytes to apoptotic death activation by the proteasome-specific inhibitor lactacystin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

SUMO: of branched proteins and nuclear bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Molecular basis of the VHL hereditary cancer syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Genome maintenance mechanisms for preventing cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Defying death after DNA damage.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Chromosomal stability and the DNA double-stranded break connection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

The Mre11 complex and ATM: collaborating to navigate S phase

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

scid cells are deficient in Ku and replication protein A phosphorylation by the DNA-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Chronic lymphocytic leukemia lymphocytes lack the capacity to repair UVC-induced lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Regulation of DNA-dependent protein kinase activity in leukemic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Characterization of a Ku86 variant protein that results in altered DNA binding and diminished DNA-dependent protein kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

DNA double strand breaks (DSB) and non-homologous end joining (NHEJ) pathways in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

The resistance of B-CLL cells to DNA damage-induced apoptosis defined by DNA microarrays.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2803%2901171-9

7 January 2021

Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1038/35010529

Identifiers

DOI

10.1016/S1470-2045(03)01171-9

1 reference

release_bjexcf3gmvcw5j26hymb6jchgi

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bjexcf3gmvcw5j26hymb6jchgi

24 November 2022

mapped directly with Wikidata item

1 reference